| Product Code: ETC6554080 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Non-alcoholic Steatohepatitis Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F |
3.3 Bulgaria Non-alcoholic Steatohepatitis Market - Industry Life Cycle |
3.4 Bulgaria Non-alcoholic Steatohepatitis Market - Porter's Five Forces |
3.5 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.7 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F |
3.8 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Bulgaria Non-alcoholic Steatohepatitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about non-alcoholic steatohepatitis (NASH) in Bulgaria |
4.2.2 Rising prevalence of obesity and diabetes in the population |
4.2.3 Technological advancements in diagnostic tools and treatment options for NASH |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for NASH diagnosis and treatment |
4.3.2 High costs associated with NASH medications and therapies |
4.3.3 Lack of approved drugs specifically targeting NASH in Bulgaria |
5 Bulgaria Non-alcoholic Steatohepatitis Market Trends |
6 Bulgaria Non-alcoholic Steatohepatitis Market, By Types |
6.1 Bulgaria Non-alcoholic Steatohepatitis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F |
6.1.4 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F |
6.1.5 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F |
6.1.6 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F |
6.1.7 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F |
6.1.8 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Bulgaria Non-alcoholic Steatohepatitis Market, By Sales Channel |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F |
6.2.4 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3 Bulgaria Non-alcoholic Steatohepatitis Market, By Disease Cause |
6.3.1 Overview and Analysis |
6.3.2 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F |
6.3.3 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F |
6.3.4 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F |
6.3.5 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3.6 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F |
6.4 Bulgaria Non-alcoholic Steatohepatitis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Bulgaria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F |
7 Bulgaria Non-alcoholic Steatohepatitis Market Import-Export Trade Statistics |
7.1 Bulgaria Non-alcoholic Steatohepatitis Market Export to Major Countries |
7.2 Bulgaria Non-alcoholic Steatohepatitis Market Imports from Major Countries |
8 Bulgaria Non-alcoholic Steatohepatitis Market Key Performance Indicators |
8.1 Number of NASH awareness campaigns conducted |
8.2 Percentage of healthcare professionals trained in NASH diagnosis and management |
8.3 Average time taken for NASH diagnosis and initiation of treatment |
8.4 Patient adherence rate to NASH treatment plans |
8.5 Number of clinical trials for NASH therapies conducted in Bulgaria |
9 Bulgaria Non-alcoholic Steatohepatitis Market - Opportunity Assessment |
9.1 Bulgaria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Bulgaria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.3 Bulgaria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F |
9.4 Bulgaria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Bulgaria Non-alcoholic Steatohepatitis Market - Competitive Landscape |
10.1 Bulgaria Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024 |
10.2 Bulgaria Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here